Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / Fund iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer Blackrock
Entity holding fund iShares VII Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF Ticker CUS1(GBX) LSE
ETF Ticker CUSS(USD) LSE
ETF Ticker SXRG(EUR) F
ETF Ticker CSUSS.MI(EUR) CXE
ETF Ticker CSUSSz(USD) CXE
ETF Ticker CUSS.LS(USD) CXE
ETF Ticker CSUSS(EUR) ETF Plus
ETF Ticker CUS1.L(GBP) LSE
ETF Ticker CUSS.L(GBP) LSE

Holdings detail for PCVX

Stock Name	Vaxcyte Inc
Ticker	PCVX(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US92243G1085
LEI	254900M7NMHTGASX8D95

Show aggregate PCVX holdings

News associated with PCVX

Vaxcyte, Inc. (NASDAQ:PCVX) Receives $106.25 Average Price Target from Analysts: Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) has received an average rating of “Buy” from the seven analysts that are currently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a hold recommendation, five have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The […] - 2025-09-16 02:32:42
Swiss National Bank Has $8.21 Million Stock Position in Vaxcyte, Inc. (NASDAQ:PCVX): Swiss National Bank reduced its holdings in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 0.8% in the 1st quarter, HoldingsChannel reports. The fund owned 217,300 shares of the company’s stock after selling 1,700 shares during the period. Swiss National Bank’s holdings in Vaxcyte were worth $8,205,000 at the end of the most recent quarter. Several […] - 2025-08-17 05:55:01
Natixis Advisors LLC Decreases Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX): Natixis Advisors LLC lowered its stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 5.7% during the first quarter, Holdings Channel reports. The institutional investor owned 14,649 shares of the company’s stock after selling 888 shares during the period. Natixis Advisors LLC’s holdings in Vaxcyte were worth $553,000 at the end of the […] - 2025-08-12 04:38:46
Analysts Forecast 12% Upside For JHML: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-07 08:57:29
KLP Kapitalforvaltning AS Buys 500 Shares of Vaxcyte, Inc. (NASDAQ:PCVX): KLP Kapitalforvaltning AS increased its stake in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 2.2% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 23,000 shares of the company’s stock after purchasing an additional 500 shares during the quarter. KLP Kapitalforvaltning AS’s holdings in Vaxcyte […] - 2025-07-29 06:16:55
Universal Beteiligungs und Servicegesellschaft mbH Buys 3,634 Shares of Vaxcyte, Inc. (NASDAQ:PCVX): Universal Beteiligungs und Servicegesellschaft mbH raised its stake in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 3.5% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 107,317 shares of the company’s stock after buying an additional 3,634 shares during the quarter. Universal […] - 2025-07-29 05:22:57
Brokerages Set Vaxcyte, Inc. (NASDAQ:PCVX) Target Price at $136.50: Shares of Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) have been given a consensus rating of “Buy” by the ten ratings firms that are covering the firm, MarketBeat Ratings reports. Nine investment analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month […] - 2025-07-28 02:30:52
New York State Common Retirement Fund Increases Holdings in Vaxcyte, Inc. (NASDAQ:PCVX): New York State Common Retirement Fund increased its stake in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 190.6% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 137,440 shares of the company’s stock after purchasing an additional 90,145 shares during the quarter. New York […] - 2025-07-22 07:09:01
Principal Financial Group Inc. Has $17.73 Million Holdings in Vaxcyte, Inc. (NASDAQ:PCVX): Principal Financial Group Inc. raised its holdings in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 52.0% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 469,561 shares of the company’s stock after acquiring an additional 160,622 shares during the period. […] - 2025-07-11 05:21:08
Calamos Advisors LLC Has $257,000 Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX): Calamos Advisors LLC decreased its stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 32.0% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 6,794 shares of the company’s stock after selling 3,201 shares during the period. Calamos Advisors LLC’s holdings in Vaxcyte were worth […] - 2025-07-08 05:46:54
Vaxcyte, Inc. (NASDAQ:PCVX) Holdings Lowered by Allspring Global Investments Holdings LLC: Allspring Global Investments Holdings LLC trimmed its stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 43.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 335,990 shares of the company’s stock after selling 257,533 shares during the […] - 2025-07-04 05:06:38
Analysts Set Vaxcyte, Inc. (NASDAQ:PCVX) Price Target at $136.50: Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) has been given a consensus rating of “Buy” by the ten ratings firms that are covering the firm, Marketbeat.com reports. Nine research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 12-month price objective among […] - 2025-07-03 02:42:45
Analyzing Vaxcyte (NASDAQ:PCVX) & Genenta Science (NASDAQ:GNTA): Genenta Science (NASDAQ:GNTA – Get Free Report) and Vaxcyte (NASDAQ:PCVX – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, risk, profitability, valuation, dividends, institutional ownership and analyst recommendations. Volatility & Risk Genenta Science has a beta of […] - 2025-06-13 02:32:52
The Math Shows ESML Can Go To $48: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-06-05 07:20:56
Vaxcyte, Inc. (NASDAQ:PCVX) Receives Average Rating of “Buy” from Brokerages: Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) has earned an average recommendation of “Buy” from the ten analysts that are currently covering the stock, Marketbeat reports. Nine investment analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month price objective among analysts […] - 2025-06-05 02:32:50
Head to Head Contrast: Vaxcyte (NASDAQ:PCVX) and Beam Therapeutics (NASDAQ:BEAM): Vaxcyte (NASDAQ:PCVX – Get Free Report) and Beam Therapeutics (NASDAQ:BEAM – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, risk, earnings and dividends. Risk and Volatility Vaxcyte has a beta of 1.27, […] - 2025-05-30 02:28:51
Millennium Management LLC Sells 21,857 Shares of Vaxcyte, Inc. (NASDAQ:PCVX): Millennium Management LLC lessened its stake in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 7.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 276,578 shares of the company’s stock after selling 21,857 shares during the quarter. Millennium Management LLC owned approximately […] - 2025-05-21 05:46:50
Vaxcyte, Inc. (NASDAQ:PCVX) Shares Bought by Dimensional Fund Advisors LP: Dimensional Fund Advisors LP increased its stake in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 115.3% during the fourth quarter, HoldingsChannel.com reports. The fund owned 293,706 shares of the company’s stock after buying an additional 157,277 shares during the period. Dimensional Fund Advisors LP’s holdings in Vaxcyte were worth $24,043,000 at the end of the […] - 2025-05-07 05:22:50
Mariner LLC Has $487,000 Position in Vaxcyte, Inc. (NASDAQ:PCVX): Mariner LLC boosted its position in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 27.7% in the 4th quarter, HoldingsChannel.com reports. The firm owned 5,947 shares of the company’s stock after buying an additional 1,290 shares during the period. Mariner LLC’s holdings in Vaxcyte were worth $487,000 as of its most recent filing with the Securities […] - 2025-05-02 05:10:52
Renaissance Technologies LLC Purchases Shares of 54,077 Vaxcyte, Inc. (NASDAQ:PCVX): Renaissance Technologies LLC acquired a new position in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 54,077 shares of the company’s stock, valued at approximately $4,427,000. A number of other hedge funds and other institutional investors […] - 2025-04-22 05:03:18
ILCB's Holdings Imply 27% Gain Potential: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-04-04 08:46:47
Norges Bank Acquires Shares of 1,100,286 Vaxcyte, Inc. (NASDAQ:PCVX): Norges Bank bought a new position in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 1,100,286 shares of the company’s stock, valued at approximately $90,069,000. Norges Bank owned about 0.88% of Vaxcyte at the end of the most […] - 2025-04-03 05:36:54
Bank of America Lowers Vaxcyte (NASDAQ:PCVX) Price Target to $137.00: Vaxcyte (NASDAQ:PCVX – Get Free Report) had its price target reduced by research analysts at Bank of America from $157.00 to $137.00 in a note issued to investors on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Bank of America‘s price objective would suggest a potential upside of 306.65% from the […] - 2025-04-03 04:24:52
Needham & Company LLC Has Lowered Expectations for Vaxcyte (NASDAQ:PCVX) Stock Price: Vaxcyte (NASDAQ:PCVX – Get Free Report) had its target price lowered by investment analysts at Needham & Company LLC from $140.00 to $90.00 in a report released on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Needham & Company LLC’s price target would suggest a potential upside of 167.14% from the […] - 2025-04-03 04:24:52
Monday's ETF Movers: FBT, XBI: In trading on Monday, the First Trust NYSE Arca Biotechnology Index Fund ETF is outperforming other ETFs, up about 1.9% on the day. Components of that ETF showing particular strength include shares of Corcept Therapeutics, up about 83.2% and shares of Amgen, up about 2% on the - 2025-03-31 13:11:30
Proficio Capital Partners LLC Invests $2.92 Million in Vaxcyte, Inc. (NASDAQ:PCVX): Proficio Capital Partners LLC purchased a new stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) during the 4th quarter, HoldingsChannel.com reports. The institutional investor purchased 35,609 shares of the company’s stock, valued at approximately $2,915,000. Several other large investors have also recently added to or reduced their stakes in the company. Whipplewood Advisors […] - 2025-03-19 05:44:45
PNC Financial Services Group Inc. Boosts Stake in Vaxcyte, Inc. (NASDAQ:PCVX): PNC Financial Services Group Inc. increased its stake in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 18.2% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 9,076 shares of the company’s stock after acquiring an additional 1,397 shares during the period. PNC Financial Services Group Inc.’s holdings […] - 2025-03-18 05:38:57
Victory Capital Management Inc. Has $24.85 Million Stock Position in Vaxcyte, Inc. (NASDAQ:PCVX): Victory Capital Management Inc. lifted its stake in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 19.0% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 303,556 shares of the company’s stock after purchasing an additional 48,516 shares during the quarter. Victory Capital Management Inc. owned […] - 2025-03-11 06:16:48
Brokerages Set Vaxcyte, Inc. (NASDAQ:PCVX) PT at $127.71: Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) has been given a consensus recommendation of “Buy” by the nine ratings firms that are covering the company, MarketBeat Ratings reports. Nine analysts have rated the stock with a buy rating. The average 1-year target price among analysts that have issued ratings on the stock in the last […] - 2025-02-28 04:06:48
After-Hours Earnings Report for February 25, 2025 : INTU, WDAY, ALC, CPNG, AXON, EXR, KEYS, FSLR, CART, CAVA, PCVX, PR: The following companies are expected to report earnings after hours on 02/25/2025. Visit our Earnings Calendar for a full list of expected earnings releases.Intuit Inc. (INTU)is reporting for the quarter ending January 31, 2025. The computer software company's consensus earnings - 2025-02-25 17:00:00

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc PCVX holdings

Date	Number of PCVX Shares Held	Base Market Value of PCVX Shares	Local Market Value of PCVX Shares	Change in PCVX Shares Held	Change in PCVX Base Value	Current Price per PCVX Share Held	Previous Price per PCVX Share Held
2025-09-26 (Friday)	62,451	USD 2,122,085	USD 2,122,085
2025-09-25 (Thursday)	62,451	USD 2,007,175	USD 2,007,175	0	USD -42,467	USD 32.14	USD 32.82
2025-09-24 (Wednesday)	62,451	USD 2,049,642	USD 2,049,642
2025-09-17 (Wednesday)	62,047	USD 1,916,322	USD 1,916,322	0	USD -21,406	USD 30.885	USD 31.23
2025-09-16 (Tuesday)	62,047	USD 1,937,728	USD 1,937,728
2025-09-12 (Friday)	61,643	USD 1,983,055	USD 1,983,055
2025-09-11 (Thursday)	61,643	USD 2,037,918	USD 2,037,918

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of PCVX by Blackrock for IE00B3VWM098

Show aggregate share trades of PCVX

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-08-21 SELL -257 31.910* 59.81 Profit of 15,372 on sale
2025-07-31 BUY 768 33.950* 60.14
2025-07-28 SELL -256 35.870* 60.60 Profit of 15,514 on sale
2025-06-30 SELL -512 32.510* 63.60 Profit of 32,563 on sale
2025-06-25 SELL -256 33.090* 64.24 Profit of 16,447 on sale
2025-06-20 SELL -514 32.870* 64.91 Profit of 33,362 on sale
2025-05-30 BUY 9,780 32.490* 68.52
2025-05-23 BUY 223 32.540* 70.04
2025-05-19 SELL -223 32.030* 71.27 Profit of 15,894 on sale
2025-05-15 SELL -669 30.900* 71.97 Profit of 48,151 on sale
2025-05-12 SELL -223 31.590* 73.10 Profit of 16,301 on sale
2025-05-09 SELL -223 31.160* 73.48 Profit of 16,386 on sale
2025-04-30 SELL -223 35.840* 76.24 Profit of 17,001 on sale
2025-04-24 SELL -446 34.510* 77.95 Profit of 34,767 on sale
2025-04-17 SELL -223 30.650* 80.44 Profit of 17,938 on sale
2025-04-15 SELL -669 30.230* 81.54 Profit of 54,552 on sale
2025-04-14 SELL -669 32.040* 82.09 Profit of 54,916 on sale
2025-04-09 SELL -892 30.800* 83.86 Profit of 74,805 on sale
2025-04-07 SELL -1,561 32.510* 85.08 Profit of 132,814 on sale
2025-04-04 SELL -2,230 31.600* 85.71 Profit of 191,138 on sale
2025-04-01 BUY 223 32.230* 86.98
2025-03-19 SELL -446 76.140* 89.22 Profit of 39,791 on sale
2025-03-17 BUY 1,330 75.230* 89.61
2025-03-14 SELL -1,314 74.370* 89.83 Profit of 118,033 on sale
2025-03-13 SELL -440 73.020* 90.07 Profit of 39,630 on sale
2025-03-12 SELL -7,480 73.240* 90.31 Profit of 675,529 on sale
2025-03-07 SELL -440 71.180* 91.24 Profit of 40,144 on sale
2025-03-06 SELL -660 74.810* 91.49 Profit of 60,382 on sale
2025-03-03 SELL -220 72.100* 92.43 Profit of 20,334 on sale
2025-02-28 SELL -1,320 73.020* 92.75 Profit of 122,425 on sale
2025-02-26 SELL -220 78.650* 93.30 Profit of 20,526 on sale
2025-02-25 SELL -660 79.350* 93.54 Profit of 61,736 on sale
2025-02-18 BUY 1,100 82.470* 94.63
2025-02-13 BUY 220 83.840* 95.27
2025-02-12 BUY 220 85.420* 95.48
2025-02-11 BUY 660 85.130* 95.69
2025-02-06 BUY 1,980 89.015* 96.24
2025-01-27 BUY 220 90.910* 97.79
2024-12-30 BUY 1,100 81.990* 99.19
2024-12-06 BUY 880 93.310* 99.91
2024-12-05 BUY 220 90.040* 100.26
2024-12-04 BUY 1,100 93.040* 100.51
2024-11-29 BUY 1,100 94.340* 101.52
2024-11-27 BUY 876 93.980* 102.18
2024-11-26 BUY 219 91.450* 102.67
2024-11-25 BUY 13,329 91.700* 103.19
2024-11-21 BUY 895 88.390* 104.74
2024-11-20 BUY 537 85.960* 105.78
2024-11-18 BUY 2,148 86.490* 108.16
2024-11-12 BUY 1,432 99.380* 108.74
2024-11-08 BUY 895 106.670* 108.89
2024-11-07 BUY 2,670 102.700* 109.36
2024-11-06 BUY 356 104.070* 109.81
2024-10-31 BUY 178 106.350* 111.25
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-08-21	SELL	-257	31.910*	59.81 Profit of 15,372 on sale
2025-07-31	BUY	768	33.950*	60.14
2025-07-28	SELL	-256	35.870*	60.60 Profit of 15,514 on sale
2025-06-30	SELL	-512	32.510*	63.60 Profit of 32,563 on sale
2025-06-25	SELL	-256	33.090*	64.24 Profit of 16,447 on sale
2025-06-20	SELL	-514	32.870*	64.91 Profit of 33,362 on sale
2025-05-30	BUY	9,780	32.490*	68.52
2025-05-23	BUY	223	32.540*	70.04
2025-05-19	SELL	-223	32.030*	71.27 Profit of 15,894 on sale
2025-05-15	SELL	-669	30.900*	71.97 Profit of 48,151 on sale
2025-05-12	SELL	-223	31.590*	73.10 Profit of 16,301 on sale
2025-05-09	SELL	-223	31.160*	73.48 Profit of 16,386 on sale
2025-04-30	SELL	-223	35.840*	76.24 Profit of 17,001 on sale
2025-04-24	SELL	-446	34.510*	77.95 Profit of 34,767 on sale
2025-04-17	SELL	-223	30.650*	80.44 Profit of 17,938 on sale
2025-04-15	SELL	-669	30.230*	81.54 Profit of 54,552 on sale
2025-04-14	SELL	-669	32.040*	82.09 Profit of 54,916 on sale
2025-04-09	SELL	-892	30.800*	83.86 Profit of 74,805 on sale
2025-04-07	SELL	-1,561	32.510*	85.08 Profit of 132,814 on sale
2025-04-04	SELL	-2,230	31.600*	85.71 Profit of 191,138 on sale
2025-04-01	BUY	223	32.230*	86.98
2025-03-19	SELL	-446	76.140*	89.22 Profit of 39,791 on sale
2025-03-17	BUY	1,330	75.230*	89.61
2025-03-14	SELL	-1,314	74.370*	89.83 Profit of 118,033 on sale
2025-03-13	SELL	-440	73.020*	90.07 Profit of 39,630 on sale
2025-03-12	SELL	-7,480	73.240*	90.31 Profit of 675,529 on sale
2025-03-07	SELL	-440	71.180*	91.24 Profit of 40,144 on sale
2025-03-06	SELL	-660	74.810*	91.49 Profit of 60,382 on sale
2025-03-03	SELL	-220	72.100*	92.43 Profit of 20,334 on sale
2025-02-28	SELL	-1,320	73.020*	92.75 Profit of 122,425 on sale
2025-02-26	SELL	-220	78.650*	93.30 Profit of 20,526 on sale
2025-02-25	SELL	-660	79.350*	93.54 Profit of 61,736 on sale
2025-02-18	BUY	1,100	82.470*	94.63
2025-02-13	BUY	220	83.840*	95.27
2025-02-12	BUY	220	85.420*	95.48
2025-02-11	BUY	660	85.130*	95.69
2025-02-06	BUY	1,980	89.015*	96.24
2025-01-27	BUY	220	90.910*	97.79
2024-12-30	BUY	1,100	81.990*	99.19
2024-12-06	BUY	880	93.310*	99.91
2024-12-05	BUY	220	90.040*	100.26
2024-12-04	BUY	1,100	93.040*	100.51
2024-11-29	BUY	1,100	94.340*	101.52
2024-11-27	BUY	876	93.980*	102.18
2024-11-26	BUY	219	91.450*	102.67
2024-11-25	BUY	13,329	91.700*	103.19
2024-11-21	BUY	895	88.390*	104.74
2024-11-20	BUY	537	85.960*	105.78
2024-11-18	BUY	2,148	86.490*	108.16
2024-11-12	BUY	1,432	99.380*	108.74
2024-11-08	BUY	895	106.670*	108.89
2024-11-07	BUY	2,670	102.700*	109.36
2024-11-06	BUY	356	104.070*	109.81
2024-10-31	BUY	178	106.350*	111.25

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of PCVX

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	204,246	81	702,291	29.1%
2025-09-18	247,318	147	1,182,122	20.9%
2025-09-17	478,618	0	1,628,296	29.4%
2025-09-16	258,632	0	784,301	33.0%
2025-09-15	193,594	318	494,380	39.2%
2025-09-12	262,307	0	527,659	49.7%
2025-09-11	181,619	0	473,839	38.3%
2025-09-10	278,938	6	810,108	34.4%
2025-09-09	197,276	1,000	484,764	40.7%
2025-09-08	356,154	300	666,464	53.4%
2025-09-05	251,668	0	581,150	43.3%
2025-09-04	288,827	4,175	579,054	49.9%
2025-09-03	282,305	0	622,626	45.3%
2025-09-02	220,320	0	734,357	30.0%
2025-08-29	107,976	0	267,835	40.3%
2025-08-28	260,554	0	594,666	43.8%
2025-08-27	179,746	0	724,103	24.8%
2025-08-26	114,100	0	664,628	17.2%
2025-08-25	196,846	0	900,657	21.9%
2025-08-22	120,850	0	342,735	35.3%
2025-08-21	153,745	120	483,243	31.8%
2025-08-20	118,380	0	353,360	33.5%
2025-08-19	113,550	0	325,277	34.9%
2025-08-18	156,869	0	446,083	35.2%
2025-08-15	144,453	1,997	521,835	27.7%
2025-08-14	214,706	0	564,088	38.1%
2025-08-13	219,025	67	1,278,221	17.1%
2025-08-12	247,228	89	705,279	35.1%
2025-08-11	233,662	136	622,096	37.6%
2025-08-08	117,171	10,841	1,145,858	10.2%
2025-08-07	318,955	20,887	1,174,518	27.2%
2025-08-06	125,483	0	261,571	48.0%
2025-08-05	114,223	106	238,075	48.0%
2025-08-04	100,205	0	238,748	42.0%
2025-08-01	140,190	2,064	321,077	43.7%
2025-07-31	128,745	0	378,867	34.0%
2025-07-30	138,630	0	351,934	39.4%
2025-07-29	181,456	445	398,378	45.5%
2025-07-28	128,910	69	541,006	23.8%
2025-07-25	143,535	100	357,219	40.2%
2025-07-24	112,578	199	342,450	32.9%
2025-07-23	116,822	100	187,700	62.2%
2025-07-22	162,681	225	214,667	75.8%
2025-07-21	255,787	100	321,419	79.6%
2025-07-18	262,894	66	397,878	66.1%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CUS1(GBX) LSE
ETF Ticker	CUSS(USD) LSE
ETF Ticker	SXRG(EUR) F
ETF Ticker	CSUSS.MI(EUR) CXE
ETF Ticker	CSUSSz(USD) CXE
ETF Ticker	CUSS.LS(USD) CXE
ETF Ticker	CSUSS(EUR) ETF Plus
ETF Ticker	CUS1.L(GBP) LSE
ETF Ticker	CUSS.L(GBP) LSE